A. Simeone

发表

Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.

R. Nieves-Alicea, A. Tari, A. Simeone, 2007, International journal of oncology.

How retinoids regulate breast cancer cell proliferation and apoptosis

A. Tari, A. Simeone, 2004, Cellular and Molecular Life Sciences CMLS.

N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.

V. Steele, C. Deng, G. Kelloff, 2005, Carcinogenesis.

Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells

R. Nieves-Alicea, A. Tari, A. Simeone, 2008, Clinical & Experimental Metastasis.

Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.

J. McMurray, F. Robertson, M. Cristofanilli, 2008, Journal of experimental therapeutics & oncology.

JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.

R. Nieves-Alicea, J. Saavedra, L. Keefer, 2011, International journal of oncology.

Cyclosporin A enhances the apoptotic effects of N‐(4‐hydroxyphenyl)retinamide in breast cancer cells

A. Tari, Chong-K. Kim, A. Simeone, 2002, International journal of cancer.

Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression

N. Colburn, R. Nieves-Alicea, A. Tari, 2009, Breast Cancer Research and Treatment.

Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4

Sukhen Ghosh, Massimo Cristofanilli, J. McMurray, 2010, Cancer.

N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.

S. Colella, A. Tari, A. Simeone, 2006, Carcinogenesis.

A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.

L. Broemeling, A. Tari, A. Simeone, 2002, Molecular cancer therapeutics.

Influence of dietary vitamins A and E on serum α- and γ-tocopherols, retinol, retinyl palmitate and carotenoid concentrations in Humboldt penguins (Spheniscus humboldti)

A. Simeone, S. Crissey, P. McGill, 1998 .

Influence of dietary vitamins A and E on serum alpha- and gamma-tocopherols, retinol, retinyl palmitate and carotenoid concentrations in Humboldt penguins (Spheniscus humboldti).

A. Simeone, S. Crissey, P. McGill, 1998, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells

R. Nieves-Alicea, J. Saavedra, L. Keefer, 2008, Breast Cancer Research.

Cyclooxygenase-2 Is Essential for HER2/neu to Suppress N- (4-Hydroxyphenyl)retinamide Apoptotic Effects in Breast Cancer Cells

L. Broemeling, Musaffe Tuna, A. Tari, 2004, Cancer Research.

T-cell receptor early signalling complex activation in response to interferon-α receptor stimulation

J. Ladbury, C. Baldari, S. John, 2010, The Biochemical journal.

Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl)retinamide inhibitory effects in breast cancer cells

W. Symmans, A. Tari, A. Simeone, 2005, Laboratory Investigation.

Combination of Paclitaxel and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer: A Phase I-II Study

A. Simeone, B. Rinaldi, F. Morelli, 2001, Journal of chemotherapy.

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production

L. Broemeling, A. Tari, A. Simeone, 2003, Oncogene.